Related Experiment Video
Updated: Jan 31, 2026

Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform
Published on: February 25, 2021
The RNA delivery dilemma-lipid versus polymer nanoparticle platforms
Cláudia Martins1,2, Michael J Mitchell3,4,5,6,7,8,9, Dan Peer10,11,12,13
1i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Rua Alfredo Allen 208, 4200-135, Porto, Portugal. claudia.martins@i3s.up.pt.
RNA delivery technologies have rapidly advanced, enabling breakthroughs in genetic diseases and vaccines. Lipid nanoparticles (LNPs) and polymer nanoparticles (PNPs) are key platforms, with nanomedicine poised to shape RNA therapy
Area of Science:
- Nanomedicine
- RNA Therapeutics
- Biotechnology
Background:
- RNA therapeutics have seen rapid expansion since their market authorization eight years ago.
- This progress spans rare genetic diseases, global vaccination, and advanced cancer vaccines.
- Sophisticated RNA delivery technologies are crucial for therapeutic success.
More Related Videos
09:39Injectable Supramolecular Polymer-Nanoparticle Hydrogels for Cell and Drug Delivery Applications
Published on: February 7, 2021
08:54Determining Four Components in a Lipid Nanoparticle RNA Delivery System by Liquid Chromatography Combined with Evaporative Light Scattering Detector
Published on: May 30, 2025
Related Concept Videos
Polymers
Polymers
Ethical Dilemmas I
Let us explore some examples to understand the potentially complex moral decisions nurses face.
Take the case of caring for minors, particularly in areas related to reproductive...
Ethical Dilemmas II
What are Lipids?
Lipid Digestion